BMAL1 and neoplasm: In SKCM, recent studies have elucidated that CRGs such as CLOCK and BMAL1 significantly influence various cellular functions including the tumor microenvironment, cell cycle, apoptosis regulation, DNA damage response, metabolic reprogramming, and immune evasion, thus affecting the response to therapy.